This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignees: Cinakate Pharm Tech (Shanghai) Co., Ltd., Cinkate Pharmaceutical Intermediates Co., Ltd.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Yufeng Zhou: Innovator in Pharmaceutical Chemistry
Introduction
Yufeng Zhou is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for medical applications. His work focuses on creating effective immunosuppressive drugs, which are crucial for various therapeutic interventions.
Latest Patents
Yufeng Zhou holds a patent for "Substituted pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors." This invention provides a method for preparing a pyrrolopyrimidine compound and its applications. Specifically, it includes a compound represented by formula I or its pharmaceutically acceptable salts, along with a pharmaceutical composition containing the compound. The patent also outlines a method for preparing the pharmaceutical composition and its application as an immunosuppressive drug. He has 1 patent to his name.
Career Highlights
Throughout his career, Yufeng Zhou has worked with several companies, including Cinakate Pharm Tech (Shanghai) Co., Ltd. and Cinkate Pharmaceutical Intermediates Co., Ltd. His experience in these organizations has allowed him to refine his skills and contribute to the advancement of pharmaceutical technologies.
Collaborations
Yufeng Zhou has collaborated with notable colleagues such as Na Liu and Lixia Bao. These partnerships have fostered a collaborative environment that enhances innovation and research in the pharmaceutical sector.
Conclusion
Yufeng Zhou is a distinguished inventor whose work in pharmaceutical chemistry has the potential to impact medical treatments significantly. His innovative approaches to drug development highlight the importance of research and collaboration in advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile